Development of novel ultra sensitive enzyme immunoassay (immune complex transfer enzyme immunoassay) for provirus DNA and virus RNA of HIV-1 (Early diagnosis of HIV-1 infection)

开发新型超灵敏酶联免疫分析法(免疫复合物转移酶联免疫分析法)检测HIV-1原病毒DNA和病毒RNA(HIV-1感染的早期诊断)

基本信息

  • 批准号:
    12672247
  • 负责人:
  • 金额:
    $ 2.11万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2000
  • 资助国家:
    日本
  • 起止时间:
    2000 至 2001
  • 项目状态:
    已结题

项目摘要

At present, though PCR, bDNA assay and NASBA are used in the measurement of provirus DNA and virus RNA such as HIV and HCV, detection limit is tens of thousand copies from several hundred. This is because the signal by the nonspecific binding of conjugates of DNA probe prevents the sensitive measurement. Then, using the novel method of 2-site binding complex transfer method which applicants developed, the specific signal was maintained, and by almost perfectly removing the non-specific signal, it was made that the ultrasensitive measurement is enabled to be a purpose. The sensitivity of RT-PCR method and the ultrasensitive 2-site binding complex transfer method of HIV-1 p24 antigen was compared by the using seroconversion panel serum. As a result, the detection period of the p24 antigen and RNA were most same time. The detection limit of RT- PCR of this experiment was the 400 copies/ml. In this time, anti-p17 IgG and IgM were early detected from p24 antigen and the virus RNA. This result showed that virus RNA was existed before the detection time of IgG and IgM. Then, the supersensitive method of amplified DNA after RT-PCR using DNA prove was developed. After hybridization of amplified DNA with both FITC and DNP labeled avidin-biotinyl DNA prove I and β-D-galactosidase labeled avidin-biotinyl DNA prove II, the complex was trapped on the anti-DNP IgG - solid phase. By excess DNP- lysine addition, the complex is eluted from the solid phase, and it is transfed on the anti-FITC IgG -solid phase. Finally, the enzyme activity on solid phase is measured.The detection limit of this transfer method was 10 amol (10^<17> mol). Because the amplification of 10^<6-8> 8copies of DNA was possible, an outlook to the detection of DNA of 6 copies was obtained.
目前,对HIV、丙型肝炎病毒等前病毒DNA和病毒RNA的检测虽然采用了聚合酶链式反应、BDNA测定法和NASBA法,但检测下限从几百个拷贝增加到几万个拷贝。这是因为DNA探针的偶联物的非特异性结合所产生的信号阻碍了灵敏的测量。然后,利用申请人开发的新方法--2位结合络合物转移法,保持了特异性信号,并几乎完美地消除了非特异性信号,使得超灵敏测量成为可能。用血清转换板血清检测HIV-1p24抗原,比较RT-PCR法和超灵敏的HIV-1p24抗原双位点结合复合体转移法的敏感性。因此,p24抗原和RNA的检测周期最长。本实验的RT-PCR检测下限为400拷贝/毫升,可从p24抗原和病毒RNA中早期检测到抗p17抗体和IgM抗体。这一结果表明,在检测到Ig G和Ig M之前,病毒RNA就已经存在。在此基础上,建立了利用DNA Proven进行RT-PCR扩增DNA的超灵敏方法。将扩增的DNA分别与FITC和DNP标记的亲和素生物素DNA pron I和β-D-半乳糖苷酶标记的亲和素生物素DNA pron II杂交后,复合物被固定在抗DNP免疫球蛋白的固相上。通过过量的DNP-赖氨酸加成,将络合物从固相中洗脱出来,并将其转移到抗FITC抗体的固相上。最后测定了酶在固相上的活力,该转移方法的检出限为10amol(10^~lt;17~gt;m ol)。由于扩增10~8个拷贝的DNA是可能的,因此对6个拷贝的DNA检测进行了展望。

项目成果

期刊论文数量(19)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Kazuya Hashinaka: "Recombinant p51 as antigen in an immune complex transfer enzyme immunoassay of immunoglobulin G antibody to human immunodeficiency virus type 1."Clinical and Diagnostic Laboratory Immunology. 7. 967-976 (2000)
Kazuya Hashinaka:“在针对人类免疫缺陷病毒 1 型的免疫球蛋白 G 抗体的免疫复合物转移酶免疫测定中,重组 p51 作为抗原。”临床和诊断实验室免疫学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kazuya Hashinaka: "Recombinant p51 as antigen in an immune complex transfer enzyme immunoassay of immunoglobulin G antibody to human immunodeficiency virus type 1"Clinical and Diagnostic Laboratory Immunology. 7. 967-976 (2000)
Kazuya Hashinaka:“在针对人类免疫缺陷病毒 1 型的免疫球蛋白 G 抗体的免疫复合物转移酶免疫测定中,重组 p51 作为抗原”临床和诊断实验室免疫学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Hideki Katakami: "Development of a highly sensitive immune complex transfer enzyme immunoassay (EIA) for rat growth hormone-releasing hormone"Clinical Pediatric Endocrinology. 10. 55-60 (2001)
Hideki Katakami:“针对大鼠生长激素释放激素的高灵敏免疫复合物转移酶免疫测定 (EIA) 的开发”临床儿科内分泌学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Setsuko Ishikawa: "Ultrasensitive enzyme immunoassay of antibody IgG to HIV-1 reverse transcriptase by immune complex transfer with detergents"Analytical Letters. 33. 2183-2196 (2000)
Setsuko Ishikawa:“通过用去污剂进行免疫复合物转移,对 HIV-1 逆转录酶抗体 IgG 进行超灵敏酶免疫测定”分析快报。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Hashinaka,Kazuya: "Recombinant p51 as antigen in an immune complex transfer enzyme immunoassay of immunoglobulin G antibody to human immunodeficiency virus type1."Clinical and Diagnostic Laboratory Immunology. 7. 967-976 (2000)
Hashinaka、Kazuya:“在针对人类免疫缺陷病毒 1 型的免疫球蛋白 G 抗体的免疫复合物转移酶免疫测定中,重组 p51 作为抗原。”临床和诊断实验室免疫学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HASHIDA Seiichi其他文献

HASHIDA Seiichi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HASHIDA Seiichi', 18)}}的其他基金

Development of a diabetes risk profile using a urinary biomarker and its application in the assessment of nutrient status and exercise levels.
使用尿液生物标志物开发糖尿病风险概况及其在营养状况和运动水平评估中的应用。
  • 批准号:
    21500701
  • 财政年份:
    2009
  • 资助金额:
    $ 2.11万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of "heterocapture sandwich EIA" and detection of the a hormone-disrupting substance
开发“异质捕获夹心EIA”并检测激素干扰物质
  • 批准号:
    17590281
  • 财政年份:
    2005
  • 资助金额:
    $ 2.11万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Studies for the Practical Use of Novel and Ultrasensitive Enzyme Immunoassay (Immune Complex Transfer Enzyme Immunoassay) of Anti-HTLV-I IgG Using Synthetic Peptides as Antigens
以合成肽为抗原的抗 HTLV-I IgG 新型超灵敏酶免疫分析(免疫复合物转移酶免疫分析)的实际应用研究
  • 批准号:
    08670154
  • 财政年份:
    1996
  • 资助金额:
    $ 2.11万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Basic Study on the Development and Application of Novel and Ultrasensitive Immunoassay for Haptens, Especially, Small Peptide Molecules
半抗原特别是小肽分子新型超灵敏免疫分析技术的开发和应用基础研究
  • 批准号:
    02808029
  • 财政年份:
    1990
  • 资助金额:
    $ 2.11万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
Basic Study on Development and Application of Ultrasensitive Enzyme Immunoassay for Interleukins
白细胞介素超灵敏酶联免疫分析法的开发及应用基础研究
  • 批准号:
    63580125
  • 财政年份:
    1988
  • 资助金额:
    $ 2.11万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似国自然基金

肽核酸(Peptide Nucleic Acid - PNA)电化学生物传感器的研究
  • 批准号:
    20703006
  • 批准年份:
    2007
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Unravelling Efficient Nucleic Acid Delivery Using Multilayer Nanoparticles
使用多层纳米粒子揭示有效的核酸输送
  • 批准号:
    DP240102642
  • 财政年份:
    2024
  • 资助金额:
    $ 2.11万
  • 项目类别:
    Discovery Projects
Nucleic acid stimulation-induced mechanism to overcome MDSC-mediated immune tolerance in tumor microenvironment
核酸刺激诱导机制克服肿瘤微环境中MDSC介导的免疫耐受
  • 批准号:
    24K18539
  • 财政年份:
    2024
  • 资助金额:
    $ 2.11万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
I-Corps: Translation potential of a miniaturized biotechnology platform for nucleic acid extraction, purification, and library preparation
I-Corps:用于核酸提取、纯化和文库制备的小型生物技术平台的转化潜力
  • 批准号:
    2421022
  • 财政年份:
    2024
  • 资助金额:
    $ 2.11万
  • 项目类别:
    Standard Grant
CAREER: Single-Molecule Study of Nucleic Acid Conformational Dynamics in Telomere
职业:端粒核酸构象动力学的单分子研究
  • 批准号:
    2338902
  • 财政年份:
    2024
  • 资助金额:
    $ 2.11万
  • 项目类别:
    Continuing Grant
Engineering of Extracellular Vesicles for Oral Delivery of Nucleic Acid Therapies
用于核酸治疗口服递送的细胞外囊泡工程
  • 批准号:
    BB/Y008065/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.11万
  • 项目类别:
    Research Grant
Exploring Nucleic Acid Aptamer Science through Electrophoretic Analysis
通过电泳分析探索核酸适体科学
  • 批准号:
    23H01991
  • 财政年份:
    2023
  • 资助金额:
    $ 2.11万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Elucidation of atopic dermatitis pathology through nucleic acid-independent single-cell microbiome analysis
通过不依赖核酸的单细胞微生物组分析阐明特应性皮炎病理学
  • 批准号:
    23H02930
  • 财政年份:
    2023
  • 资助金额:
    $ 2.11万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Elucidation of the molecular link between DNA repair and mitochondrial nucleic acid metabolism
阐明DNA修复和线粒体核酸代谢之间的分子联系
  • 批准号:
    23K07078
  • 财政年份:
    2023
  • 资助金额:
    $ 2.11万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Rapid viral diagnostics reagents, without the need for nucleic acid
快速病毒诊断试剂,无需核酸
  • 批准号:
    600561
  • 财政年份:
    2023
  • 资助金额:
    $ 2.11万
  • 项目类别:
    EU-Funded
Developing a nucleic acid force field with direct chemical perception for computational modeling of nucleic acid therapeutics
开发具有直接化学感知的核酸力场,用于核酸治疗的计算建模
  • 批准号:
    10678562
  • 财政年份:
    2023
  • 资助金额:
    $ 2.11万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了